{
"source_attachment": {
"filename": "cardionova_no_rem(2).jpg",
"path": ""
},
"document": {
"document_type": "advertisement",
"title_or_product": "CardioNova XR",
"summary": "Text-only CardioNova XR advertisement presenting cardiovascular-protection claims, including two prominent statements of up to 60% lower heart-attack risk, supporting copy about a once-daily tablet and CardioShield™ formula, and a prompt to ask a healthcare professional. Analysis follows the supplied instruction to use only visible content. "
},
"regions": [
{
"id": "r01",
"type": "headline",
"bbox": [0.325, 0.078, 0.676, 0.111],
"text": "CardioNova XR",
"description": "Large bold black product name centred near the top of the advert.",
"semantic_role": "Identifies and brands the advertised product.",
"fields": {
"SD": {
"score": 0.0,
"reason": ""
},
"ED": {
"score": 0.0,
"reason": ""
},
"CF": {
"score": 0.0,
"reason": ""
},
"VPF": {
"score": 0.0,
"reason": ""
},
"SCF": {
"score": 0.0,
"reason": ""
},
"RSF": {
"score": 0.0,
"reason": ""
}
}
},
{
"id": "r02",
"type": "product_claim",
"bbox": [0.311, 0.123, 0.688, 0.139],
"text": "A NEW STANDARD IN HEART PROTECTION",
"description": "Red uppercase strapline centred below the product name.",
"semantic_role": "Positions the product as a new or improved means of protecting heart health.",
"fields": {
"SD": {
"score": 0.0,
"reason": ""
},
"ED": {
"score": 0.45,
"reason": "The product is presented as a new standard in heart protection without visible supporting evidence or comparison."
},
"CF": {
"score": 0.35,
"reason": "The phrase 'heart protection' sounds medically substantive but does not specify what protection means or how it is measured."
},
"VPF": {
"score": 0.05,
"reason": "The wording provides a very weak aspirational cue of preserved health."
},
"SCF": {
"score": 0.1,
"reason": "The claim presents the product as having a medically relevant protective effect on the heart."
},
"RSF": {
"score": 0.0,
"reason": ""
}
}
},
{
"id": "r03",
"type": "statistic",
"bbox": [0.076, 0.154, 0.924, 0.224],
"text": "Cut your heart-attack risk by up to 60%.",
"description": "Large bold black risk-reduction statement centred inside a wide pale-grey banner.",
"semantic_role": "Presents a prominent quantitative benefit claim as the main advertising message.",
"fields": {
"SD": {
"score": 0.0,
"reason": ""
},
"ED": {
"score": 0.95,
"reason": "The specific up-to-60% heart-attack-risk reduction is given without any visible study, source, population, timeframe, methodology, or other evidential grounding."
},
"CF": {
"score": 0.2,
"reason": "The outcome is comparatively definite, but the wording does not state the timeframe, reference risk, population, or conditions associated with the percentage."
},
"VPF": {
"score": 0.0,
"reason": ""
},
"SCF": {
"score": 0.15,
"reason": "A claimed reduction of heart-attack risk implies a substantial medically relevant effect."
},
"RSF": {
"score": 0.25,
"reason": "The large high-contrast benefit claim receives strong visual prominence with no safety or risk information presented alongside it."
}
}
},
{
"id": "r04",
"type": "scientific_claim",
"bbox": [0.09, 0.253, 0.91, 0.292],
"text": "CardioNova XR combines next-generation cardiovascular science with a once-daily tablet designed to\nprotect your heart before problems begin.",
"description": "Two centred lines of black body text describing cardiovascular science, a once-daily tablet, and preventative heart protection.",
"semantic_role": "Provides scientific and medical framing for the advertised preventative benefit.",
"fields": {
"SD": {
"score": 0.15,
"reason": "The phrase 'next-generation cardiovascular science' supplies scientific texture without identifying a particular scientific development or mechanism."
},
"ED": {
"score": 0.7,
"reason": "The product-specific claim that the tablet is designed to protect the heart before problems begin is unsupported by visible evidence."
},
"CF": {
"score": 0.75,
"reason": "The phrases 'next-generation cardiovascular science' and 'protect your heart before problems begin' imply technical and preventative specificity without defining a mechanism, endpoint, or measurable process."
},
"VPF": {
"score": 0.05,
"reason": "Preventing future heart problems provides a weak aspirational health cue."
},
"SCF": {
"score": 0.2,
"reason": "A once-daily tablet claimed to produce preventative cardiovascular effects implies non-trivial biological activity."
},
"RSF": {
"score": 0.1,
"reason": "The passage describes only protective benefits of the tablet and presents no accompanying safety information."
}
}
},
{
"id": "r05",
"type": "scientific_claim",
"bbox": [0.082, 0.3, 0.92, 0.338],
"text": "Its advanced CardioShield™ formula helps strengthen arterial resilience, improve circulation and support\nlong-term cardiovascular performance.",
"description": "Two centred lines of black body text naming the CardioShield™ formula and listing three cardiovascular benefits.",
"semantic_role": "Uses branded scientific-sounding terminology and physiological benefit language to explain the product's claimed effects.",
"fields": {
"SD": {
"score": 0.3,
"reason": "The branded 'CardioShield™ formula' and the phrase 'arterial resilience' create scientific-looking explanatory structure without visible definition or explanation."
},
"ED": {
"score": 0.8,
"reason": "Claims that this product strengthens arterial resilience, improves circulation, and supports cardiovascular performance are presented without visible supporting evidence."
},
"CF": {
"score": 0.85,
"reason": "Terms including 'advanced CardioShield™ formula', 'arterial resilience', and 'cardiovascular performance' convey technical specificity while leaving the relevant mechanisms and measurable quantities undefined."
},
"VPF": {
"score": 0.05,
"reason": "The reference to long-term cardiovascular performance provides a weak aspirational health cue."
},
"SCF": {
"score": 0.25,
"reason": "Claims of strengthening arteries and improving circulation imply physiologically meaningful biological effects."
},
"RSF": {
"score": 0.1,
"reason": "The passage lists several physiological benefits without accompanying safety information."
}
}
},
{
"id": "r06",
"type": "body_text",
"bbox": [0.087, 0.347, 0.912, 0.366],
"text": "Why wait for a warning sign? Ask your healthcare professional whether CardioNova XR is right for you.",
"description": "Single centred line asking a rhetorical question and directing the reader to a healthcare professional.",
"semantic_role": "Creates urgency and provides a medical call to action.",
"fields": {
"SD": {
"score": 0.0,
"reason": ""
},
"ED": {
"score": 0.0,
"reason": ""
},
"CF": {
"score": 0.0,
"reason": ""
},
"VPF": {
"score": 0.0,
"reason": ""
},
"SCF": {
"score": 0.0,
"reason": ""
},
"RSF": {
"score": 0.0,
"reason": ""
}
}
},
{
"id": "r07",
"type": "statistic",
"bbox": [0.076, 0.376, 0.924, 0.434],
"text": "UP TO 60% LOWER HEART-ATTACK RISK",
"description": "Large bold red uppercase risk-reduction statement centred in a wide pale-pink banner.",
"semantic_role": "Repeats and visually reinforces the advert's principal quantitative benefit claim.",
"fields": {
"SD": {
"score": 0.0,
"reason": ""
},
"ED": {
"score": 0.95,
"reason": "The repeated up-to-60% heart-attack-risk reduction has no visible source, study details, population, timeframe, or methodology."
},
"CF": {
"score": 0.2,
"reason": "The claimed outcome is relatively definite, but the percentage lacks a stated timeframe, reference risk, population, or qualifying conditions."
},
"VPF": {
"score": 0.0,
"reason": ""
},
"SCF": {
"score": 0.15,
"reason": "The magnitude of the claimed heart-attack-risk reduction implies a substantial medically relevant effect."
},
"RSF": {
"score": 0.3,
"reason": "The benefit statistic is repeated in a large coloured banner while no safety or risk disclosure is displayed with comparable prominence."
}
}
}
],
"global_fields": {
"SD": {
"score": 0.25,
"summary": "The advert uses some scientifically textured terminology, especially 'next-generation cardiovascular science', 'CardioShield™ formula', 'arterial resilience', and 'cardiovascular performance', but it does not visibly present an overtly impossible scientific proposition."
},
"ED": {
"score": 0.9,
"summary": "The advert is dominated by product-specific efficacy claims, particularly the repeated up-to-60% heart-attack-risk reduction, without visible studies, sources, methodology, population, timeframe, or other evidential grounding."
},
"CF": {
"score": 0.75,
"summary": "Much of the supporting copy creates an impression of cardiovascular and technical specificity while leaving key processes and quantities undefined, especially through 'next-generation cardiovascular science', 'CardioShield™ formula', 'arterial resilience', and 'cardiovascular performance'."
},
"VPF": {
"score": 0.05,
"summary": "There is no lifestyle or vitality imagery; only weak aspirational health cues appear in language about protection, prevention, and long-term cardiovascular performance."
},
"SCF": {
"score": 0.2,
"summary": "The advert contains no explicit adverse-effect or contraindication information, but its once-daily tablet and claims of altering cardiovascular risk, arterial resilience, and circulation imply medically meaningful biological activity."
},
"RSF": {
"score": 0.3,
"summary": "Large and repeated benefit claims dominate the visual hierarchy, including two prominent statements of up to 60% lower heart-attack risk, while no visible safety warning or risk disclosure receives comparable presentation."
}
}
}